Marseille, France

Bruno Lebrun

This inventor holds 1 USPTO granted patent. Top assignee: Suntory Limited. Active years: 2004.


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 15(Granted Patents)


Company Filing History:


Years Active: 2004

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Bruno Lebrun

Introduction

Bruno Lebrun, an inventive mind based in Marseilles, France, has made his mark in the field of biotechnology. His innovative work focuses on neuropeptides derived from scorpions, showcasing his dedication to advancing scientific knowledge. With a single patent to his name, Lebrun represents the potential for significant contributions in the realm of biochemistry.

Latest Patents

Bruno Lebrun holds a patent related to "Neuropeptides originating in scorpion." This groundbreaking work sheds light on the applications of these neuropeptides, possibly paving the way for advancements in medical treatments and therapeutic uses.

Career Highlights

At present, Bruno Lebrun is employed by Suntory Limited, a globally recognized company known for its diverse range of products, including beverages and health-related innovations. His experience in a prominent organization equips him with the resources to channel his inventive spirit into impactful projects.

Collaborations

Throughout his career, Bruno has collaborated with a variety of talented professionals, including Régine Romi-Lebrun and Hiroyuki Minakata. These partnerships foster a creative environment, allowing for the sharing of ideas and expertise that drives innovation forward.

Conclusion

Bruno Lebrun exemplifies the impact that dedicated inventors can have in the world of science and technology. With his innovative patent on neuropeptides and valuable collaborations, he continues to enhance the field and inspire future discoveries. As his career evolves, the contributions of this visionary inventor will undoubtedly play a crucial role in shaping advancements within biotechnology.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…